跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-MIRTAZAPINE mirtazapine 30 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
APO-MIRTAZAPINE mirtazapine 30 mg tablet bottle
Approved
STANDARD
APO-MIRTAZAPINE mirtazapine 30 mg tablet bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
29a460e344181598
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
29a460e344181598
Product Name
APO-MIRTAZAPINE mirtazapine 30 mg tablet bottle
Artg Id
127677
Artg Name
APO-MIRTAZAPINE mirtazapine 30 mg tablet bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2007-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/168a106a1e7086bc3a7f1723ef630d94.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
29a460e344181598
Type
Standard
Back to TGA Approvals
